MC10 grabs $19.8M more to advance stretchable sensors for med tech

The Bay State's MC10--a maker of stretchable sensors useful for medical devices and other applications--reeled in $19.8 million in new funding, according to a regulatory filing.

The Boston Business Journal reported on Cambridge-based MC10's latest equity financing, which comes on top of an $18 million funding round in April. MC10's filing doesn't disclose the investors behind the round. But as the BBJ noted, Braemar Energy Ventures and North Bridge Venture Partners are among the company's previous investors. Medtronic ($MDT) is also an investor and has partnered with MC10 to use its BioStamp stretchable sensor technology in a balloon catheter, a bid to develop a device that can open up vessels and simultaneously collect data on heart function and potential vascular problems.

In July, MC10 heralded a deal with Reebok ($RBK) that produced a device worn on the head to detect head trauma severity in contact sports such as football. While not designed to function as a diagnostic, the product is designed to help reduce the risk of serious injury by determining an athlete's condition on the field.

- here's the SEC filing
- check out the BBJ's take

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.